Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
19/09/2025
In early trading on Thursday, the Travelers Companies Inc., a component of the Dow Jones Industrial Average, rose 0.74%, continuing its gains from yesterday.
Latest
3 m ago
S&P Global Ratings Report: Canadian telecommunications companies may reduce leverage ratio by 2026.
3 m ago
S&P Global Ratings Report: Canadian telecommunications companies may reduce their leverage ratio by 2026.
6 m ago
In the field of biomedicine, some domestically produced innovative drugs have shown effectiveness comparable to those of international pharmaceutical star products. In recent years, more and more international pharmaceutical companies have invested heavily in collaborating with Chinese pharmaceutical companies. Earlier this year, China's artificial intelligence model DeepSeek attracted worldwide attention with its low development cost and powerful performance. In fact, in the field of biotechnology, China is also experiencing a similar "DeepSeek moment". Chinese pharmaceutical companies are transitioning from the era of generic drugs to the era of innovative drugs and are attracting numerous international collaborations. The main form of collaboration is through licensing agreements, where the foreign party obtains the rights to develop, produce, and commercialize Chinese drugs or related technologies in markets outside of China. (CCTV Finance)
6 m ago
President Trump of the United States is seeking to accelerate the development of power plants, power lines, and other energy projects to help meet the growing electricity demands of artificial intelligence (AI) and the manufacturing industry.
7 m ago
Goldman Sachs appoints Ben Snider as the new head of US stock strategy.
See all latest